N/A N=48 Randomized Treatment

Additional Gluteal Control Training for Low Back Pain With Functional Leg Length Inequality

Low Back Pain, Recurrent

Bottom Line

View on ClinicalTrials.gov: NCT03554746 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2019

Primary outcome: Primary: Leg Length Inequality — 0.3; 0.58 centemeter

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: GC group (Other); CG group (Other)
Age: Adult, Older Adult · 20+ yrs
Sex: All
Sponsor: National Yang Ming Chiao Tung University
Primary completion: Jul 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Leg Length Inequality	0.3; 0.58	—
PRIMARY Ilium Anterior Tilt Difference	0.67; 2.27	—
PRIMARY Pelvic Inclination	1.03; 1.56	—
SECONDARY Pain Intensity	1.3; 3.44	—
SECONDARY Functional Disability	7.51; 11.91	—
SECONDARY Functional Ability	8.23; 7.09	—

Summary

Low back pain (LBP) is a prevalent musculoskeletal disorder. A variety of exercise interventions which were designed as randomized control trails (RCTs) have been studied and shown effectiveness in improving pain and disability. These exercises typically focus on the abdominal and back musculature strength. However, many LBP patients did not show any improvement in their symptom after they carry out those exercise programs.

Eligibility Criteria

Inclusion Criteria

non-specific LBP (from inferior rib margin to the gluteal fold)
more than 3 months
Visual Analog Scale ≧5 (in past one month)
pelvic innominate rotation (anterior rotation in dominant side)

Exclusion Criteria

history of fracture or surgery
congenital anomalies in the spine, pelvis, or lower limbs
recent trauma, tumor, pregnancy or scoliosis
lower extremity paresthesia, unknown weakness
bowel and bladder dysfunction
predominant lower extremity pain with standing
presence of system illness, no reasoning weight loss, predominant night pain
specific sacroiliac joint dysfunction

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03554746). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.